Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization S Bansod, N Doijad, C Godugu Toxicology and Applied Pharmacology 403, 115162, 2020 | 37 | 2020 |
Borneol protects against cerulein‐induced oxidative stress and inflammation in acute pancreatitis mice model S Bansod, S Chilvery, MA Saifi, TJ Das, H Tag, C Godugu Environmental Toxicology 36 (4), 530-539, 2021 | 33 | 2021 |
Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways S Chilvery, S Bansod, MA Saifi, C Godugu International Immunopharmacology 88, 106909, 2020 | 32 | 2020 |
Crocin, an active constituent of Crocus sativus ameliorates cerulein induced pancreatic inflammation and oxidative stress C Godugu, LP Pasari, A Khurana, P Anchi, MA Saifi, SP Bansod, ... Phytotherapy research 34 (4), 825-835, 2020 | 32 | 2020 |
Nimbolide ameliorates pancreatic inflammation and apoptosis by modulating NF-κB/SIRT1 and apoptosis signaling in acute pancreatitis model S Bansod, C Godugu International Immunopharmacology 90, 107246, 2021 | 24 | 2021 |
Molecular updates on berberine in liver diseases: bench to bedside S Bansod, MA Saifi, C Godugu Phytotherapy Research 35 (10), 5459-5476, 2021 | 23 | 2021 |
Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating β-catenin/Smad in a sirtuin-dependent way S Bansod, MA Saifi, A Khurana, C Godugu Pharmacological Research 156, 104756, 2020 | 22 | 2020 |
Cerulein-induced chronic pancreatitis in Swiss albino mice: An improved short-term model for pharmacological screening S Bansod, A Khurana, C Godugu Journal of pharmacological and toxicological methods 96, 46-55, 2019 | 18 | 2019 |
Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities S Bansod, PB Dodhiawala, KH Lim Cancers 13 (21), 5481, 2021 | 13 | 2021 |
Acetaminophen induced hepatotoxicity: An overview of the promising protective effects of natural products and herbal formulations S Chilvery, A Yelne, A Khurana, MA Saifi, S Bansod, P Anchi, C Godugu Phytomedicine 108, 154510, 2023 | 12 | 2023 |
New 3‐(1H‐benzo[d]imidazol‐2‐yl)quinolin‐2(1H)‐one‐based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis … NB Gaikwad, S Bansode, S Biradar, M Ban, N Srinivas, C Godugu, ... Archiv der Pharmazie 354 (11), 2100074, 2021 | 9 | 2021 |
Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model S Bansod, MA Saifi, C Godugu Scientific Reports 11 (1), 12894, 2021 | 8 | 2021 |
COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives MA Saifi, S Bansod, C Godugu Drug Discovery Today 27 (11), 103345, 2022 | 7 | 2022 |
Design, synthesis, and biological evaluation of N-(4-substituted)-3-phenylisoxazolo [5, 4–d] pyrimidin-4-amine derivatives as apoptosis-inducing cytotoxic agents NB Gaikwad, S Bansod, A Mara, R Garise, N Srinivas, C Godugu, ... Bioorganic & Medicinal Chemistry Letters 49, 128294, 2021 | 7 | 2021 |
A brief cross-cultural ethnobotanical note on the Abotani tribes of Arunachal Pradesh, India H Yanka, R Rinyo, SK Das, TJ Das, D Paul, DD Gupta, PK Hui, S Bansod, ... Pleione 13 (2), 269-283, 2019 | 6 | 2019 |
Ethnobotanical notes on significant food and medicinal flora used by the indigenous Monpa and Nyishi communities of Arunachal Pradesh, India SK Das, TJ Das, D Tshering, J Tsering, D Paul, DD Gupta, H Yanka, ... Pleione 13, 291-304, 2019 | 4 | 2019 |
Exploration of cytotoxic potential and tubulin polymerization inhibition activity of cis-stilbene-1, 2, 3-triazole congeners D Bora, KM Samir, A Sharma, S Chilvery, S Bansod, SE John, MA Khan, ... RSC Medicinal Chemistry 14 (3), 482-490, 2023 | 3 | 2023 |
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer A Bulle, P Liu, K Seehra, S Bansod, Y Chen, K Zahra, V Somani, ... Nature Communications 15 (1), 2503, 2024 | 2 | 2024 |
A pilot study of paricalcitol plus nanoliposomal irinotecan and 5-FU/LV in advanced pancreatic cancer patients after progression on gemcitabine-based therapy PM Grierson, R Suresh, B Tan, KS Pedersen, M Amin, H Park, ... Clinical Cancer Research 29 (23), 4733-4739, 2023 | | 2023 |
A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy. P Grierson, R Suresh, BR Tan, KS Pedersen, MA Amin, H Park, ... Journal of Clinical Oncology 41 (16_suppl), e16263-e16263, 2023 | | 2023 |